‘Doctor Who’ companion Elisabeth Sladen dies at age 63

Springs Hosting

Elisabeth SladenI never wanted to see these words, much less type them: Elisabeth Sladen, the former Doctor Who co-star who went on many years later to star in her own spin-off The Sarah Jane Adventures, has died at the age of 63.

The cause of her death was cancer, according to the BBC.

Sladen first joined Doctor Who in 1973 opposite Jon Pertwee, and stayed for Tom Baker’s formative years in the role. She would return for an abortive spinfoff, K-9 and Company, a series of full-cast audio dramas and various TV reunion episodes before getting her own series, finally, in 2007. The show has seen four successful seasons, with a fifth greenlit.

Just a couple months ago her Doctor Who co-star Nicholas Courtney passed away at the age of 81. There will be a U.N.I.T. reunion in heaven tonight…

Current Doctor Who producer Steven Moffat said of Sladen:

“Sarah Jane Smith was everybody’s hero when I was younger, and as brave and funny and brilliant as people only ever are in stories. But many years later, when I met the real Sarah Jane – Lis Sladen herself – she was exactly as any child ever have wanted her to be. Kind and gentle and clever; and a ferociously talented actress, of course, but in that perfectly English unassuming way.

BBC report

The Associated Press report

AP obituary

Airlock Alpha

Sarah Jane Smith (BBC)

Subscribe for free updates!


View previous campaigns.

Powered by MailChimp

Nerdvana Media will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at news@nerdvanamedia.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.